Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -9366.75% is 553% below its 3-year average of -1434.17%, near the low end of its 3-year range (-10039.18%–0.00%).
179.91% below its 12-month average of -3346.39%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2025 (2025-12-31): -10039.18%.
NET PROFIT MARGIN
-9366.75%
NET PROFIT MARGIN AVG TTM
-3346.39%
NET PROFIT MARGIN AVG 3Y
-1434.17%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-179.91%
CURRENT VS 3Y AVG
-553.11%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-3602496.15%
vs the sector median at left
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Market Cap
$5.82M
Net Profit Margin
-9366.75%
TTM Avg
-3346.39%
3Y Avg
-1434.17%
5Y Avg
N/A
Market Cap
$5.83M
Net Profit Margin
-225.28%
TTM Avg
-379.90%
3Y Avg
-549.78%
5Y Avg
-669.44%
Market Cap
$5.89M
Net Profit Margin
-10.33%
TTM Avg
-20.23%
3Y Avg
-29.31%
5Y Avg
-29.79%
Market Cap
$5.73M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-86.55%
Market Cap
$5.92M
Net Profit Margin
-44771.83%
TTM Avg
-33930.36%
3Y Avg
-151894.64%
5Y Avg
-112740.11%
Market Cap
$5.70M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.63M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.11M
Net Profit Margin
-4620.92%
TTM Avg
-1491.69%
3Y Avg
-1081.40%
5Y Avg
-732.36%
Market Cap
$6.28M
Net Profit Margin
-534.27%
TTM Avg
-983.65%
3Y Avg
-1060.24%
5Y Avg
-924.37%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) | $5.82M | -9366.75% | -3346.39% | -1434.17% | N/A |
| Lucyd, Inc (LUCY)vs › | $5.83M | -225.28% | -379.90% | -549.78% | -669.44% |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.89M | -10.33% | -20.23% | -29.31% | -29.79% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.73M | 0.00% | 0.00% | 0.00% | -86.55% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.92M | -44771.83% | -33930.36% | -151894.64% | -112740.11% |
| enVVeno Medical Corporation (NVNO)vs › | $5.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Scienture Holdings, Inc. (SCNX)vs › | $6.11M | -4620.92% | -1491.69% | -1081.40% | -732.36% |
| Femasys Inc. (FEMY)vs › | $6.28M | -534.27% | -983.65% | -1060.24% | -924.37% |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | -3985.58% | -1467.13% | -2181.72% | -1717.85% |
Operating Margin
-9154.6%
Net Profit Margin
-9366.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | -10039.18% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-06-30 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-06-30 | 0.00% |
| 2022-12-31 | 0.00% |
